Transarterial Chemoembolization for Hepatitis B Virus–associated Hepatocellular Carcinoma: Improved Survival after Concomitant Treatment with Nucleoside Analogues-Reference-Cited by-同舟云学术

Transarterial Chemoembolization for Hepatitis B Virus–associated Hepatocellular Carcinoma: Improved Survival after Concomitant Treatment with Nucleoside Analogues

Published:2012-03 Issue:3 Volume:23 Page:317-322.e1
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Toyoda Hidenori,Kumada Takashi,Tada Toshifumi,Sone Yasuhiro,Fujimori Masashi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference34 articles.

1. L'embolisation arterielle hepatique dans les tumeurs malignes du foie;Doyon;Ann Radiol,1974

2. Transcatheter arterial embolization therapy in unresectable hepatomas—experience in 15 cases;Yamada;Acta Hepatol Japon,1979

3. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan;Toyoda;Clin Gastroenterol Hepatol,2006

4. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies;Brown;J Vasc Interv Radiol,2009

5. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma;Kumada;Hepatology,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraarterial Therapies for the Management of Hepatocellular Carcinoma;Cancers;2022-07-10

2. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?;International Journal of Molecular Sciences;2022-01-02

3. Effect of antiviral therapy in patients with low HBV DNA level on transarterial chemoembolization for hepatocellular carcinoma;Journal of Viral Hepatitis;2021-04-05

4. Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy;MINERVA GASTROENTERO;2021

5. Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy;Minerva Gastroenterology;2021-03